Clinical practice. Latent tuberculosis infection in the United States

N Engl J Med. 2011 Apr 14;364(15):1441-8. doi: 10.1056/NEJMcp1005750.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Antigens, Bacterial
  • Antitubercular Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Global Health
  • Humans
  • Interferon-gamma / analysis*
  • Interferon-gamma / metabolism
  • Isoniazid / therapeutic use
  • Mycobacterium tuberculosis / immunology*
  • Mycobacterium tuberculosis / physiology
  • Practice Guidelines as Topic
  • Rifampin / therapeutic use
  • Tuberculosis / diagnosis*
  • Tuberculosis / drug therapy*
  • Virus Latency

Substances

  • Antigens, Bacterial
  • Antitubercular Agents
  • Interferon-gamma
  • Isoniazid
  • Rifampin